Category Archives: Bisphosphonates

Featured Stories
Former Executives Accuse Health Technology Firm of Fraud

Former Executives Accuse Health Technology Firm of Fraud

Former NantHealth executives claim that the company made fraudulent claims about the reliability of its system, which links patient information gathered by the devices.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Boston Scientific Transvaginal Mesh

Tennessee Woman Alleges Boston Scientific Transvaginal Mesh Product Caused Painful Injuries

More reports of painful injuries are being linked to transvaginal mesh. This time, a Tennessee woman has filed a lawsuit against Boston Scientific over its Advantage Transvaginal Mid-Urethral Sling System.

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Metal-on-Metal Hip Replacement Concerns Grow in Canada

Canadian patients and doctors are voicing more concerns about metal-on-metal hip replacements, as health regulators around the world continue to investigate the safety of the devices. According to a report from the CBC, four companies have recently either recalled or suspended sales of metal-on-metal hip replacement devices, while a number ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

New York City Council Calls for Zadroga Act to be Renewed

New York City Council Calls for Zadroga Act to be Renewed

New York City Council members are calling for the Zadroga Act, which provides compensation and medical treatment to 9/11 victims, to be renewed.

Read More

Bisphosphonates Associated with Increased Risk of Atypical Hip Fractures, Researcher Says

The use of bisphosphonates, drugs prescribed to prevent hip fractures in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint. The research is contained in a PhD thesis by Javier Gorricho-Mendívil, at the NUP/UPNA-Public … Continue reading

Posted in Bisphosphonates, Fosamax, Health Concerns, Pharmaceuticals |

Study: Bisphosphonates Use Raises Risks for Atrial Fibrillation

bisphosphonate_atrial_fibrilation

New research has found that bisphosphonate use was tied to a significant increased risk of both atrial fibrillation (AF) and serious AF. Bisphosphonates include Fosamax (alendronate sodium), Reclast and Zometa (zoledronic acid), Boniva (ibandronate sodium), Didronel (etidronate disodium), Actonel (risedronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman Alleges Bisphosphonates Led to “Dead Jaw”

actonel_dead_jaw

We’ve long been following risks associated with bisphosphonate (BP) drugs like Fosamax, Boniva, and Actonel, which are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients also often undergo therapy with Aredia, Zometa, and other bisphosphonate drugs … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Bisphosphonates Increase Bone Disease Risks Following Tooth Extraction

We’ve been following risks associated with bisphosphonate (BP) drugs. As we’ve explained, some bisphosphonates, like Fosamax, Boniva, and Actonel, are approved to treat bone-weakening diseases like osteoporosis and Paget’s disease. Cancer patients often undergo therapy with Aredia, Zometa, and other … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Woman who suffered jawbone loss due to Fosamax reaches damages settlement with Merck

A woman who claims her taking Fosamax in the prevention of bone loss caused by osteoporosis resulted in her developing decay of her jaw bone has reached a confidential settlement with the makers of the drug. Merck & Co. has … Continue reading

Posted in Bisphosphonates, Fosamax, Legal News, Pharmaceuticals | Tagged , |

Bisphosphonate drugs Fosamax, Boniva not right for women in “pre-menopause”

Women suffering from osteopenia, often referred to as pre-menopause, should avoid taking bisphosphonate drugs like Fosamax to prevent bone loss in most circumstances. Consumer Reports magazine’s team of medical experts issued this advisory when questioned about the use of these … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged , |

Study Finds Dental Work Triggers Bisphosphonate-Induced ONJ in Blood Cancer Patients

Dental extractions appear to be a major trigger for Ostenecrosis of the Jaw (ONJ) in people receiving bisphosphonates to treat multiple myeloma or Waldenstrom’s macroglobulinemia, says a new study out of Italy.  According to the authors of the report, which … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Rhode Island Woman’s Lawsuit Claims Fosamax Caused Painful Femur Fracture

Yet another woman who used Fosamax has filed a lawsuit claiming the bisphosphonate drug caused her to suffer a painful femur fracture.  This new lawsuit was filed on June 22nd in the Superior Court of New Jersey, Atlantic County Law … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Lawsuit Alleges Woman Suffered Femur Fracture Due to Fosamax

National law firm, Parker Waichman LLP, just filed a lawsuit on behalf of a woman who took Fosamax (alendronate) and subsequently suffered a femur fracture; the lawsuit alleges that Merck’s osteoporosis drug caused the fracture. The Fosamax lawsuit was filed … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals | Tagged |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.